Europe - Frankfurt Stock Exchange - FRA:GIS - US3755581036 - Common Stock
Overall GIS gets a fundamental rating of 6 out of 10. We evaluated GIS against 86 industry peers in the Biotechnology industry. While GIS has a great profitability rating, there are some minor concerns on its financial health. GIS may be a bit undervalued, certainly considering the very reasonable score on growth GIS also has an excellent dividend rating. These ratings would make GIS suitable for value and dividend investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.86% | ||
| ROE | 37.8% | ||
| ROIC | 18.54% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.96% | ||
| PM (TTM) | 27.88% | ||
| GM | 78.72% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 1.17 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.06 | ||
| Fwd PE | 14.73 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.15 | ||
| EV/EBITDA | 10.91 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.61% |
ChartMill assigns a fundamental rating of 6 / 10 to GIS.DE.
ChartMill assigns a valuation rating of 8 / 10 to GILEAD SCIENCES INC (GIS.DE). This can be considered as Undervalued.
GILEAD SCIENCES INC (GIS.DE) has a profitability rating of 8 / 10.
The financial health rating of GILEAD SCIENCES INC (GIS.DE) is 5 / 10.
The Earnings per Share (EPS) of GILEAD SCIENCES INC (GIS.DE) is expected to grow by 80.49% in the next year.